Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Mauricio Sarmiento Maldonado"'
Autor:
Mauricio Sarmiento Maldonado, Pablo Ramírez Villanueva, Pablo Bertín Cortes-Monroy, Veronica Jara Arias, Katherine Soto Donoso, Pablo Uribe Gonzalez, Mauricio Ocqueteau Tachini, Jose Antonio Perez-Simón
Publikováno v:
Experimental Hematology & Oncology, Vol 6, Iss 1, Pp 1-9 (2017)
Abstract Background Ruxolitinib is a potent inhibitor of JAK1/2 with proven efficacy in myelofibrosis. In recent years, research in graft versus host disease (GVHD) has revealed the role of activation of JAK pathways in alloreactive lymphocytes. Some
Externí odkaz:
https://doaj.org/article/7840b2d58f9743b79988cbc36a8f2f07
Autor:
Mauricio Sarmiento Maldonado, Mauricio Ocqueteau Tachini, Javier Pilcante, Pablo Ramírez Villanueva
Publikováno v:
Medwave, Vol 15, Iss 07, Pp e6207-e6207 (2015)
INTRODUCCIÓN La leucemia mieloide aguda tiene una alta mortalidad sin tratamiento. El trasplante hematopoyético es la única estrategia curativa hasta ahora. Los pacientes que tienen contraindicaciones para el trasplante, pueden ser tratados con f
Externí odkaz:
https://doaj.org/article/b39ff14ebdd446348fd0ea0d51ce413d
Autor:
Marcela Espinoza Zelada, Nicole Befferman Cordova, Mauricio Ocqueteau Tachin, Pablo Ramírez Villanueva, Mauricio Galleguillos M., Mauricio Sarmiento Maldonado
Publikováno v:
Medwave, Vol 15, Iss 02, p e6098 (2015)
INTRODUCTION Bortezomib is a selective inhibitor of the proteosoma that is used in multiple myeloma. In combination with other antineoplastic drugs, it has a well-documented impact in progression-free survival rates and overall survival rates with s
Externí odkaz:
https://doaj.org/article/a4d614086e9840a29865d4cce0b65845
Autor:
Soto Katherine, Pablo Bertin, Isabel Pizarro, Jaime Pereira, Jara Veronica, Isabel Leiva Rodríguez, Mauricio Sarmiento Maldonado, Carla Lorca, Silvana Arellano, Elizabeth Rivera, Mauricio Ocqueteau, Nicole Beffermann, Mauricio Galleguillos
Publikováno v:
Blood. 134:5641-5641
Introduction Autologous hematopoietic transplantation (autoHT) is an effective treatment in myeloma and lymphoma patients. To perform it, an adequate harvest of stem cells is required. Collection of stem cells can be challenging in some patients, bec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::76ec5d7c921e46c50cd59b33bf020e1a
https://doi.org/10.1182/blood-2019-124328
https://doi.org/10.1182/blood-2019-124328
Autor:
Vicente Sandoval, Mauricio Galleguillos, Silvana Arellano, Jaime Pereira, Pablo Bertin, Elizabeth Rivera, Isabel Leiva Rodríguez, Carla Lorca, Mauricio Ocqueteau, Andres Rojas, Nicolás Triantafilo, Soto Katherine, Isabel Pizarro, Felipe Palacios, Mauricio Sarmiento Maldonado, Jara Veronica, James Campbell
Publikováno v:
Blood. 134:5683-5683
Introduction Steroids refractory (SR) acute (a) or chronic (c) graft versus host disease (GVHD) carries morbidity and lethality. Treatment algorithms varies widely among institutions meaning that the most effective treatment is not yet established. E
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1233f32e15782da01540bdeb632f75d7
https://doi.org/10.1182/blood-2019-131737
https://doi.org/10.1182/blood-2019-131737
Publikováno v:
Medwave, Vol 15, Iss 07, Pp e6207-e6207 (2015)
Acute myeloid leukemia has a high mortality if untreated. Hematopoietic stem cell transplantation is the only curative treatment so far. Patients who are not eligible to receive a transplant can be treated with hypomethylating agents that have shown
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84be236f0950d74bcb3502b084fee826
http://www.medwave.cl/link.cgi/Medwave/Estudios/Investigacion/6207
http://www.medwave.cl/link.cgi/Medwave/Estudios/Investigacion/6207
Autor:
Pablo Lira Vergara, Pablo Bertin Cortes-Monroy, Mauricio Ocqueteau Tachini, María Rodríguez, Pablo Villanueva, Mauricio Sarmiento Maldonado, Maria Alejandra Rodríguez Inglés
Publikováno v:
Revista médica de Chile v.143 n.6 2015
SciELO Chile
CONICYT Chile
instacron:CONICYT
SciELO Chile
CONICYT Chile
instacron:CONICYT
Thrombotic thrombocytopenic purpura, an immune/non-immune thrombotic microangiopathy (TTP/TMA) is associated with high morbidity and mortality, even with appropriate treatment. In patients refractory to standard treatment with plasmapheresis there is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa962db974c8ca8726f438caf21152ce
http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872015000600016
http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872015000600016
Autor:
Mauricio Ocqueteau Tachini, Mauricio Galleguillos M, Nicole Befferman Cordova, Marcela Espinoza Zelada, Pablo Villanueva, Mauricio Sarmiento Maldonado
Publikováno v:
Medwave, Vol 15, Iss 02, p e6098 (2015)
Bortezomib is a selective inhibitor of the proteosoma that is used in multiple myeloma. In combination with other antineoplastic drugs, it has a well-documented impact in progression-free survival rates and overall survival rates with standard doses
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67adbe96049c1dbc423890921a322a20
http://www.medwave.cl/link.cgi/Medwave/Estudios/Investigacion/6098
http://www.medwave.cl/link.cgi/Medwave/Estudios/Investigacion/6098
Autor:
Mauricio, Sarmiento Maldonado, Pablo, Bertín Cortés-Monroy, Pablo, Lira Vergara, María Alejandra, Rodríguez Ingles, María José, García Rodríguez, Pablo, Ramírez Villanueva, Mauricio, Ocqueteau Tachini
Publikováno v:
Revista medica de Chile. 143(6)
Thrombotic thrombocytopenic purpura, an immune/non-immune thrombotic microangiopathy (TTP/TMA) is associated with high morbidity and mortality, even with appropriate treatment. In patients refractory to standard treatment with plasmapheresis there is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::3ee1f3340a328f8ed3ceeaa8c075065e
https://pubmed.ncbi.nlm.nih.gov/26230566
https://pubmed.ncbi.nlm.nih.gov/26230566